Aluminum and Alzheimer's Disease

Area of Science:

• Environmental Science
• Toxicology
• Neuroscience

Background:

• Aluminum (Al) is abundant and widely used, raising concerns about human health toxicity.
• While generally considered safe due to low absorption and efficient excretion, factors can increase Al bioavailability and lead to chronic exposure.
• Al toxicity is known to cause encephalopathy, anemia, and bone disease, particularly in dialyzed patients.

Purpose of the Study:

• To investigate the neurotoxic effects of aluminum (Al) and its potential role in Alzheimer's disease (AD).
• To examine metabolic impairment and iron (Fe) alterations associated with Al neurotoxicity.
• To discuss the influence of sex and genetic differences on Al risk assessment.

Main Methods:

• Literature review focusing on Al bioavailability, toxicity, and neurodegenerative disease.
• Analysis of studies examining metabolic and iron alterations in relation to Al exposure.
• Discussion of epidemiological data and risk assessment factors.

Main Results:

• Chronic, low-dose aluminum exposure can lead to silent accumulation and adverse health effects.
• Al exposure is linked to metabolic disturbances and altered iron homeostasis, key factors in neurotoxicity.
• Sex and genetic variations may significantly impact individual susceptibility and risk assessment for Al toxicity.

Conclusions:

• Aluminum's ubiquitous nature necessitates a thorough understanding of its potential chronic health impacts, especially neurotoxicity.
• Further research is needed to clarify the controversial link between low-dose aluminum exposure and Alzheimer's disease.
• Considering biological variability is crucial for accurate human health risk assessment of aluminum exposure.